Skip to main content

Orbita for Pharmaceuticals & Life Sciences

Conversational AI that mirrors human behavior while delivering patient support resources and HCP education on demand, 24/7

  • FOR PATIENT SUPPORT

    • Drive 24/7 access to credible, on-label drug information to empower consumers & patients
    • Provide support tools during patient journey to increase adherence during prescribed dose schedule
    • Escalate questions & detect adverse events with built-in connection capabilities with call centers
  • FOR HCPS & MEDICAL AFFAIRS

    • Provide HCPs with 24/7 access to latest medical & clinical information at their moment of need
    • Increase engagement opportunities and/or reduce costs by augmenting sales process
    • Escalate questions & detect adverse events with built-in connection capabilities with call centers

Request a demo, trial, or consultation to support patients and/or HCPs with secure, HIPAA-compliant conversational experiences.

FOR PATIENT SUPPORT Increase patient encounters and adherence rates by augmenting existing patient resources

  • Consumer brand awareness & education
  • Assist patients/caregivers in FAQs
  • First-time use instructions/videos
  • Disease resource support
  • Multi-lingual support
  • Emotional support
  • Fill/refill notifications
  • Treatment maintenance
  • Patient satisfactions survey(s)
  • Gather insights & data to personalize future patient experiences
  • Financial assistance programs
  • On-call program
  • Adverse events

FOR HCPs & MEDICAL AFFAIRS Continue to sell and adapt to key challenges by augmenting existing sales and educational tools

  • Brand awareness
  • Onboarding education
  • On and off-label FAQs
  • Multi-lingual support
  • Replicate services offered by sales teams in F2F meetings (during pandemic & beyond)
  • Gather HCP insights & data to inform future sales decisions
  • Adverse events
  • Product complaints
  • Call center escalation

Resources for Pharma & Life Sciences

NEW: ORBITA LAUNCHES ADVERSE EVENT DETECTION MODULE TO EASE REPORTING BURDENS

In the past two years, over two million adverse event reports were submitted to the FDA by patients and healthcare providers. Each year, over 770,000 people are injured or die from adverse drug events. Chatbots are an increasingly popular tool for pharmaceutical brand marketing and patient support, but few are equipped to accurately flag if a patient is having a medication-induced side effect, which can hinder pharmacovigilance processes and success.

Orbita’s new platform-agnostic adverse event detection module integrates into existing chat services to accurately detect and seamlessly assist users in reporting adverse reactions to medications, ultimately improving the efficiency and timeliness of adverse event reporting.